GEN Exclusives

More »

GEN News Highlights

More »
Aug 12, 2013

Epistem Wins Grant to Develop Point-of-Care HepC Tests

  • Epistem has just received €1.5 million (approximately $1.99 million) in funding over a three-year period by the European Commission's 7th Framework Program as part of a €6.0 million (around $7.97 million) consortium project for the development of point-of-care (PoC) hepatitis C assays. 

    Epistem will develop a number of tests on its hand-held PCR platform Genedrive®, which can provide genotype test results. The assays that Epistem is planning to develop include tests to detect and genotype the hepatitis C virus, develop hepatitis C viral load tests to monitor patient treatments, and ascertain the IL-28b genotype of hepatitis C-infected patients to help select patients who will respond to treatment with pegylated-interferon/ribavirin therapy.

    The PoC-HCV consortium, of which Inserm (Institut Pasteur), Inserm Transfert, Qlucore, and Biosurfit are also members, aims to provide PoC diagnostic and predictive tests that enable tangible improvements in the health and quality of life of chronic hepatitis C patients, while at the same time helping to manage the rising cost of medical treatment. The consortium claims that this approach capitalizes on their collective experience with miniaturized molecular testing, lab-on-a-disk systems, and treatment algorithm design, technologies it believes will permit the development and delivery of the first integrated genetic and protein biomarker tests, applied here to hepatitis C disease.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Tackling Climate Change

Do you think most companies will respond positively to the People’s Climate March?